Telix Pharmaceuticals Ltd.'s total assets for Q2 2024 were AU$745.96M, an increase of 87.28% from the previous quarter. AU:TLX total liabilities were AU$341.98M for the fiscal quarter, a 37.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.